Canaccord Genuity reiterates a 'Buy' on Anacor Pharma (ANAC); Good Risk/Reward Going Into Ph3 Data for Tava

Go back to Canaccord Genuity reiterates a 'Buy' on Anacor Pharma (ANAC); Good Risk/Reward Going Into Ph3 Data for Tava